REDAPT Anteverted Cemented Liner
K-Number: K160923 · 2016-11-17
ApplicantSmith & Nephew, Inc.
Decision Date2016-11-17
Product CodeJDI
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
REDAPT Anteverted Cemented Liner is a medical device manufactured by Smith & Nephew, Inc.. It received FDA 510(k) clearance on 2016-11-17 under approval number K160923. The device is classified under product code JDI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the REDAPT Anteverted Cemented Liner?
REDAPT Anteverted Cemented Liner is a medical device that received FDA 510(k) clearance on 2016-11-17. It is manufactured by Smith & Nephew, Inc.. The 510(k) number is K160923.
When was REDAPT Anteverted Cemented Liner approved by the FDA?
REDAPT Anteverted Cemented Liner received FDA 510(k) clearance on 2016-11-17, under approval number K160923.
What company makes REDAPT Anteverted Cemented Liner?
REDAPT Anteverted Cemented Liner is manufactured by Smith & Nephew, Inc..
What is the FDA product code for REDAPT Anteverted Cemented Liner?
The FDA product code for REDAPT Anteverted Cemented Liner is JDI.
Other Devices by Smith & Nephew, Inc.
Related Devices (Code: JDI)
K153057FitRite Total Hip Arthroplasty SystemExcera Orthopedics, Inc.
K153725Corin TaperFit Hip StemCorin U.S.A. Limited
K153216Alpine Cemented Hip SystemOrtho Development Corporation
K162125MALUC Total Hip Arthroplasty SystemSurgtech, Inc.
K180973Libertas Hip Replacement SystemMaxx Orthopedics, Inc.
K191414EXETER Centralizer, EXETER 2.5mm PlugStryker Orthopaedics
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.